REMINDER: Our focusIR Investor Webinar takes place TONIGHT with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDuke Capital Regulatory News (DUKE)

Share Price Information for Duke Capital (DUKE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 33.00
Bid: 32.50
Ask: 33.50
Change: 0.00 (0.00%)
Spread: 1.00 (3.077%)
Open: 33.00
High: 33.00
Low: 33.00
Prev. Close: 33.00
DUKE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

13 Sep 2023 07:00

RNS Number : 2324M
Duke Royalty Limited
13 September 2023
 

13 September 2023

Duke Royalty Limited

("Duke Royalty", "Duke" or the "Company")

Trading Update

 

Duke Royalty, a provider of alternative capital solutions to a diversified range of profitable and long-established businesses in Europe and North America, is pleased to provide the following trading and operational update for its first quarter of the financial year 2024, ending 30 June 2023 ("Q1 FY24"). The Company also provides guidance on trading for its second quarter, ending 30 September 2023 ("Q2 FY24").

 

Q1 FY24 Financial Highlights:

 

· Recurring cash revenue for Q1 FY24 reached a new record of £6.0 million, an increase of 17% over Q1 FY23, and a £300,000 increase on the prior quarter

· The £6.0 million for the quarter meant Duke delivered an average monthly recurring cash revenue of £2.0 million for the first time in the Company's history, a significant milestone

· Q1 FY24 total cash revenue reached £7.8 million, marking another quarterly cash revenue record, surpassing the previous record of £6.7 million in Q4 FY22, on account of the Instor buyback

· 0.70p interim dividend paid out in April 2023

Overview of quarterly revenue growth:

 

Recurring Cash Revenue*

Total Cash Revenue**

Q1 FY23

£5.1 million

£5.1 million

Q2 FY23

£5.3 million

£5.3 million

Q3 FY23

£5.6 million

£5.6 million

Q4 FY23

£5.7 million

£5.8 million

Q1 FY24

£6.0 million

£7.8 million

 

* Recurring cash revenue excludes buyback premium receipts and cash gains from equity sales

** Total cash revenue is monthly cash distributions from Duke's royalty partners plus cash gains received from the sales of equity assets and buyback premiums

 

 

Q1 FY24 Operational Highlights:

· In May 2023, Duke announced the successful exit of its investment in royalty partner Instor Solutions, Inc. Duke received net cash of US$11.2 million at closing, delivering a total gain of US$2.4 million and a triple-digit IRR

· Duke also completed two material follow-on investments in the quarter as follows:

- a £1.9 million investment into New Path Fire and Security to facilitate its acquisition of BDI Security Limited

- a £1.8 million investment int Tristone Healthcare to enable the company to complete its acquisition of South West Intervention Service Limited

 

Financial Forecast for Q2 FY24:

 

· Based on current trading, Duke expects to achieve recurring cash revenue of £6.2 million in Q2 FY24

· The £6.2 million of cash revenue would represent a 17% year-on-year increase (Q2 FY23: £5.3 million) and a further increase on Q1 FY24

 

Neil Johnson, CEO of Duke Royalty, said:

 

"We are pleased to report another quarter marked by record-breaking cash performance, underpinned by solid growth. This underscores the resilience of Duke's business model, especially in the face of ongoing economic challenges. Looking ahead, we remain confident that the consistent quarterly growth we have generated in recurring revenue will continue, and Duke is committed to working with our partners for their long-term growth."

 

Change of Name of Nominated Adviser and Joint Broker

 

The Company also announces that its Nominated Adviser and Joint Broker has changed its name to Cavendish Securities plc following completion of its own corporate merger.

 

***ENDS***

 

For further information, please visit www.dukeroyalty.com or contact:

 

 

Duke Royalty Limited

Neil Johnson / Charles Cannon Brookes / Hugo Evans

 

 

+44 (0) 1481 730 613

Cavendish Securities plc 

(Nominated Adviser

and Joint Broker)

 

Stephen Keys / Callum Davidson / Michael Johnson

 

+44 (0) 207 397 8900

 

Canaccord Genuity

(Joint Broker)

 

Adam James / Harry Rees

+44 (0) 207 523 8000

SEC Newgate (PR)

Elisabeth Cowell / Alice Cho / Matthew Elliott

+44 (0) 20 3757 6882 dukeroyalty@secnewgate.co.uk

 

About Duke Royalty

 

Duke Royalty Limited provides alternative capital solutions to a diversified range of profitable and long-established businesses in Europe and abroad. Duke Royalty's experienced team provide financing solutions to private companies that are in need of capital but whose owners wish to maintain equity control of their business. Duke Royalty's royalty investments are intended to provide robust, stable, long term returns to its shareholders. Duke Royalty is listed on the AIM market under the ticker DUKE and is headquartered in Guernsey.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTBLLLFXKLBBBB
Date   Source Headline
27th Jul 20202:05 pmRNSSecond Price Monitoring Extn
27th Jul 20202:00 pmRNSPrice Monitoring Extension
15th Jul 20207:00 amRNSDirector/PDMR Shareholding
3rd Jul 20203:15 pmRNSIssue of Equity for Scrip Dividend
2nd Jul 20207:00 amRNSScrip Dividend Reference Price
18th Jun 20207:00 amRNSFollow-on contribution to royalty partner
17th Jun 20207:01 amRNSDividend Declaration
17th Jun 20207:00 amRNSIssue of Equity
14th May 20202:05 pmRNSSecond Price Monitoring Extn
14th May 20202:00 pmRNSPrice Monitoring Extension
14th May 20207:00 amRNSTrading and Dividend Update
6th May 20204:42 pmRNSSecond Price Monitoring Extn
6th May 20204:36 pmRNSPrice Monitoring Extension
5th May 20204:45 pmRNSHolding(s) in Company
2nd Apr 20207:00 amRNSTrading Update re: COVID-19
16th Mar 20204:41 pmRNSSecond Price Monitoring Extn
16th Mar 20204:35 pmRNSPrice Monitoring Extension
16th Mar 20207:00 amRNSFollow-on contribution to royalty partner
11th Mar 20207:01 amRNSDividend Declaration & Trading Update
11th Mar 20207:00 amRNSDirectorate Change
30th Jan 20207:00 amRNSFollow-on contribution to royalty partner
23rd Jan 202012:35 pmRNSHolding(s) in Company
13th Jan 20207:00 amRNSPortfolio Update
9th Jan 20205:23 pmRNSHolding(s) in Company
9th Jan 20205:20 pmRNSHolding(s) in Company
16th Dec 20197:00 amRNSDividend Declaration
6th Dec 20197:01 amRNSLong Term Incentive Plan Awards
6th Dec 20197:00 amRNSInterim Results
4th Nov 20197:00 amRNSPaydown of Revolving Credit Facility
1st Nov 20197:00 amRNSFollow-on contribution to royalty partner
31st Oct 20193:19 pmRNSDirectors' Dealings
30th Oct 20191:55 pmRNSResult of EGM and Issue of £17.5 million of Equity
25th Oct 20197:00 amRNSNotification of major holdings
16th Oct 201911:26 amRNSResult of Annual General Meeting
7th Oct 20197:00 amRNSResult of Retail Offer and Open Offer Details
4th Oct 20194:31 pmRNSRetail Offer via PrimaryBid.com
4th Oct 20194:30 pmRNSFundraising of up to £20 million
19th Sep 20197:00 amRNSIncreased Interim Dividend & Dividend Declaration
18th Sep 20197:00 amRNSPosting of Report & Accounts and Notice of AGM
10th Sep 20197:00 amRNSIncreased £30M Credit Facility on Improved Terms
9th Sep 20197:00 amRNSFiscal 2019 Final Results
29th Aug 20197:00 amRNSFollow-On Contribution and Restructuring
14th Aug 20197:00 amRNSUpdate and Notice of Results
25th Jul 20195:51 pmRNSNotification of major holdings
19th Jun 20197:00 amRNSDividend Declaration
28th May 20197:00 amRNSFollow-on contribution to royalty partner
14th May 20191:00 pmRNSModification of Partners' Agreements - Amendment
14th May 20197:00 amRNSModification of Partners' Agreements
7th May 20197:00 amRNSNotification of major holdings
22nd Mar 20197:00 amRNSDirector's Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.